Bio Green Med Solution, Inc.
BGMS Nasdaq· Wholesale-Durable Goods, Nec
Last close · Oct 23, 2026
$0.96
KIRA · Stoqly’s AI analyst, in plain words
- Bio Green Med Solution, Inc. had $0.0M of revenue in fiscal 2025, down 100.0% on the year before.
- Bio Green Med Solution, Inc. lost $3.0M in fiscal 2025.
Market cap
$5.4M
P/E
—
Revenue
$0.0M
Net income
−$3.0M
Free cash flow
—
Operating margin
—
Bio Green Med Solution, Inc. in 30 seconds · fiscal 2025
Are sales growing?
−100.0%
No. Sales fell 100.0% last year.
Does it make a profit?
−$3.0M
No. It lost money last year.
How healthy are the accounts?
2 / 7
Weak. It passes 2 of 7 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Bio Green Med Solution, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 30, 2026
- Legal name
- Bio Green Med Solution, Inc.
- CIK
- 0001130166
Bio Green Med Solution, Inc. · BGMS
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $0.0M | $0.0M | $0.4M | $0.0M | $0.0M |
| Revenue growth | — | — | — | −89.8% | −100.0% |
| Net interest income | — | — | — | $0.0M | $0.1M |
| Operating margin | — | — | −6,060.2% | −27,916.3% | — |
| Net income | −$18.5M | −$21.2M | −$22.6M | −$11.2M | −$3.0M |
| Net margin | — | — | −5,370.2% | −26,074.4% | — |
| Diluted EPS | −$2.09 | −$27.24 | −$6,419.18 | −$502.46 | −$6.45 |
| Cash | |||||
| Cash from operations | −$18.5M | −$20.8M | −$16.1M | −$8.0M | −$4.8M |
| Capital expenditure | $0.0M | $0.0M | $0.0M | — | — |
| Free cash flow | −$18.6M | −$20.8M | −$16.1M | — | — |
| FCF margin | — | — | −3,837.6% | — | — |
| Share count change | 145.7% | 26.1% | −68.5% | −99.4% | 9,698.7% |
| Debt and strength | |||||
| Cash and short-term investments | $41.0M | $22.9M | $3.4M | $3.1M | $3.5M |
| Shareholders' equity | $37.7M | $15.9M | $0.6M | −$2.2M | $6.8M |
| Current ratio | 7.6x | 3.3x | 0.9x | 0.6x | 4.7x |
| Returns and quality | |||||
| Return on equity | −52.0% | −79.0% | −272.6% | — | −128.4% |
| Return on tangible equity | −49.0% | −133.0% | −3,748.9% | — | −267.3% |
| Piotroski F-score | 0 | 1 | 3 | 2 | 2 |
| Altman Z'' | −19.9 | −47.6 | −178.5 | −374.2 | −178.6 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$1.4M
3 insiders
Of sales under plans
0%
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Bio Green Med Solution, Inc. · BGMS
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $0.96 a share, the company is worth $5.4M.
Source: SEC EDGAR XBRL filings (CIK 0001130166). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.